Literature DB >> 25469779

Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.

Dipti Kakkar Thukral, Shweta Dumoga, Anil K Mishra1.   

Abstract

Development of colloidal delivery systems has opened new avenues/frontiers for improving drug delivery. Solid lipid nanoparticles have come up as the latest development in the arena of lipid based colloidal delivery systems after nanoemulsion and liposomes ever since their introduction in the early 1990s. In this review, the authors have made efforts to bring forth the essential and practically relevant aspects of SLNs. This review gives an overview of the preparation methods of solid lipid nanoparticles while mainly focussing on their biological applications including their projected applications in drug delivery. This review critically examines the influential factors governing the formation of SLNs and then discussing in detail the several techniques being utilized for their characterization. This review discusses the drug loading and drug release aspects of SLNs as these are useful biocompatible carriers of lipophilic and to a certain extent hydrophilic drugs. An updated list of drugs encapsulated into various lipids to prepare SLN formulations has been provided. Other relevant aspects pertaining to the clinical use of SLN formulations like their sterilization and storage stability have also been explained. A unique facet of this review is the discussion on the challenging issues of in vivo applications and recent progresses in overcoming these challenges which follows in the end.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25469779     DOI: 10.2174/156720181106141202122335

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  9 in total

1.  Sialic acid-modified solid lipid nanoparticles as vascular endothelium-targeting carriers for ischemia-reperfusion-induced acute renal injury.

Authors:  Jing-Bo Hu; Gui-Ling Song; Di Liu; Shu-Juan Li; Jia-Hui Wu; Xu-Qi Kang; Jing Qi; Fei-Yang Jin; Xiao-Juan Wang; Xiao-Ling Xu; Xiao-Ying Ying; Lian Yu; Jian You; Yong-Zhong Du
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.819

2.  Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.

Authors:  Bilin Liu; Dan He; Jianyong Wu; Quan Sun; Mi Zhang; Qunyou Tan; Yao Li; Jingqing Zhang
Journal:  Oncotarget       Date:  2017-05-09

Review 3.  The antimicrobial activity of nanoparticles: present situation and prospects for the future.

Authors:  Linlin Wang; Chen Hu; Longquan Shao
Journal:  Int J Nanomedicine       Date:  2017-02-14

4.  Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.

Authors:  Shuqin Ni; Lei Qiu; Guodong Zhang; Haiyan Zhou; Yong Han
Journal:  Int J Nanomedicine       Date:  2017-02-27

5.  Characterization of Silver Nanomaterials Derived from Marine Streptomyces sp. Al-Dhabi-87 and Its In Vitro Application against Multidrug Resistant and Extended-Spectrum Beta-Lactamase Clinical Pathogens.

Authors:  Naif Abdullah Al-Dhabi; Abdul-Kareem Mohammed Ghilan; Mariadhas Valan Arasu
Journal:  Nanomaterials (Basel)       Date:  2018-04-26       Impact factor: 5.076

Review 6.  A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery.

Authors:  Sonia Pandey; Farhinbanu Shaikh; Arti Gupta; Purnima Tripathi; Jitendra Singh Yadav
Journal:  Adv Pharm Bull       Date:  2021-05-16

7.  Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.

Authors:  Mingfeng Shao; Wenfang Yang; Guangying Han
Journal:  Int J Nanomedicine       Date:  2017-09-26

Review 8.  Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge.

Authors:  Partha Karmakar; Vishwanath Gaitonde
Journal:  Medicines (Basel)       Date:  2019-01-31

9.  High anticancer efficacy of solid lipid nanoparticles containing Zataria multiflora essential oil against breast cancer and melanoma cell lines.

Authors:  Alireza Valizadeh; Ali Asghar Khaleghi; Ghazaal Roozitalab; Mahmoud Osanloo
Journal:  BMC Pharmacol Toxicol       Date:  2021-09-30       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.